Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Background A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy r...

Full description

Saved in:
Bibliographic Details
Published in:Journal of thrombosis and haemostasis Vol. 18; no. 5; pp. 1094 - 1099
Main Authors: Tang, Ning, Bai, Huan, Chen, Xing, Gong, Jiale, Li, Dengju, Sun, Ziyong
Format: Journal Article
Language:English
Published: England Elsevier Limited 01.05.2020
International Society on Thrombosis and Haemostasis. Published by Elsevier Inc
Subjects:
ISSN:1538-7933, 1538-7836, 1538-7836
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first